Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$192.5 - $216.35 $126,280 - $141,925
-656 Reduced 2.72%
23,473 $4.78 Million
Q1 2024

May 09, 2024

BUY
$209.01 - $232.56 $453,551 - $504,655
2,170 Added 9.88%
24,129 $5.27 Million
Q4 2023

Feb 12, 2024

SELL
$197.69 - $227.29 $1.43 Million - $1.64 Million
-7,210 Reduced 24.72%
21,959 $4.99 Million
Q3 2023

Nov 13, 2023

SELL
$201.05 - $221.7 $919,803 - $1.01 Million
-4,575 Reduced 13.56%
29,169 $5.86 Million
Q2 2023

Aug 14, 2023

SELL
$211.93 - $241.33 $121,859 - $138,764
-575 Reduced 1.68%
33,744 $8.14 Million
Q1 2023

May 10, 2023

SELL
$213.32 - $257.83 $258,543 - $312,489
-1,212 Reduced 3.41%
34,319 $7.87 Million
Q4 2022

Feb 08, 2023

SELL
$203.72 - $248.97 $993,338 - $1.21 Million
-4,876 Reduced 12.07%
35,531 $8.37 Million
Q3 2022

Nov 14, 2022

SELL
$204.81 - $262.19 $1.13 Million - $1.44 Million
-5,501 Reduced 11.98%
40,407 $8.28 Million
Q2 2022

Aug 16, 2022

BUY
$213.86 - $277.87 $344,528 - $447,648
1,611 Added 3.64%
45,908 $10.8 Million
Q1 2022

May 13, 2022

SELL
$259.82 - $298.18 $1.04 Million - $1.2 Million
-4,016 Reduced 8.31%
44,297 $11.7 Million
Q4 2021

Feb 10, 2022

SELL
$271.6 - $314.21 $4 Million - $4.63 Million
-14,722 Reduced 23.36%
48,313 $15.2 Million
Q3 2021

Nov 15, 2021

SELL
$274.82 - $308.34 $1.69 Million - $1.9 Million
-6,156 Reduced 8.9%
63,035 $17.7 Million
Q2 2021

Aug 12, 2021

BUY
$251.87 - $278.14 $397,702 - $439,183
1,579 Added 2.34%
69,191 $19.1 Million
Q1 2021

May 14, 2021

SELL
$204.88 - $255.03 $677,538 - $843,384
-3,307 Reduced 4.66%
67,612 $17.2 Million
Q4 2020

Feb 12, 2021

BUY
$186.91 - $214.42 $1.49 Million - $1.71 Million
7,989 Added 12.7%
70,919 $14.4 Million
Q3 2020

Nov 17, 2020

BUY
$167.03 - $201.3 $10.5 Million - $12.7 Million
62,930 New
62,930 $11.8 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.6B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Te Ahumairangi Investment Management LTD Portfolio

Follow Te Ahumairangi Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Te Ahumairangi Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Te Ahumairangi Investment Management LTD with notifications on news.